Oral delivery of nucleic acid vaccines by particulate complexes
US6475995B1 · kind B1 · utility
33Cited by
9References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 1999 |
| Grant date | Nov 5, 2002 |
| Priority date | — |
| Expiry date | Jan 15, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/918
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Nanoparticle coacervates of nucleic acids and polycations serve as effective vaccines when administered orally. They can induce immunity to a variety of disease causing agents and raise a protective response to allergens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.